axanum 81 mg/20 mg hartkapseln
astrazeneca gmbh (3079338) - acetylsalicylsäure (ph.eur.); esomeprazol-hemimagnesium 1.5 h<2>o - hartkapsel - teil 1 - hartkapsel; acetylsalicylsäure (ph.eur.) (00002) 81 milligramm; esomeprazol-hemimagnesium 1.5 h<2>o (30966) 22,3 milligramm
seroquel prolong 150 mg retardtabletten
astrazeneca gmbh (3079338) - quetiapinfumarat (ph.eur.) - retardtablette - quetiapinfumarat (ph.eur.) (30625) 172,69 milligramm
seroquel 200 mg filmtabletten
astrazeneca gmbh (3079338) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 230,26 milligramm
seroquel 100 mg filmtabletten
astrazeneca gmbh (3079338) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 115,13 milligramm
seroquel 25 mg filmtabletten
astrazeneca gmbh (3079338) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 28,78 milligramm
seroquel 300 mg filmtabletten
astrazeneca gmbh (3079338) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 345,39 milligramm
imfinzi
astrazeneca ab - durvalumab - karzinom, nicht kleinzellige lunge - antineoplastische mittel - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
casodex 150 mg filmtabletten
astrazeneca gmbh (3079338) - bicalutamid - filmtablette - teil 1 - filmtablette; bicalutamid (25764) 150 milligramm
zomig 2,5 mg schmelztabletten
astrazeneca gmbh (3079338) - zolmitriptan - schmelztablette - teil 1 - schmelztablette; zolmitriptan (27191) 2,5 milligramm
zomig 5 mg schmelztabletten
astrazeneca gmbh (3079338) - zolmitriptan - schmelztablette - teil 1 - schmelztablette; zolmitriptan (27191) 5 milligramm